Nuvation Bio (NUVB) Non-Current Debt: 2025
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Summit Therapeutics | 1,387.71B | 1,387.50B | - | - |
| 2 | BeOne Medicines | 458.68B | 457.16B | 1.15B | 146.09M |
| 3 | Vertex Pharmaceuticals | 102.37B | 99.35B | - | - |
| 4 | Benitec Biopharma | 65.38B | 65.31B | - | - |
| 5 | Regeneron Pharmaceuticals | 60.67B | 60.28B | - | 1.99B |
| 6 | Alnylam Pharmaceuticals | 60.53B | 62.66B | - | - |
| 7 | Argenx Se | 45.96B | 50.00B | - | - |
| 8 | INSMED | 26.50B | 27.40B | - | 538.51M |
| 9 | BioNTech SE | 25.15B | 17.24B | - | 43.89M |
| 10 | Nuvation Bio | 1.42B | 1.38B | 2.26M | 46.97M |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 47.09M |
| Sep 30, 2025 | 47.09M |
| Jun 30, 2025 | 46.97M |
| Jun 30, 2025 | 46.97M |